Kenneth M. Peters

Kenneth M. Peters

Urology
3601 West 13 Mile Road
2 South
Royal Oak, MI 48073

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications

Fractional carbon dioxide vaginal laser for the treatment of urinary symptoms: 36-month results.

Fractional carbon dioxide vaginal laser for the treatment of urinary symptoms: 36-month results.

Journal: International urology and nephrology
Published: June 09, 2026

Clinical phenotypes and treatment patterns in men with chronic pelvic pain: a tertiary referral cohort.

Clinical phenotypes and treatment patterns in men with chronic pelvic pain: a tertiary referral cohort.

Journal: International urology and nephrology
Published: March 31, 2026

Editorial Comment.

Editorial Comment.

Journal: The Journal of urology
Published: February 13, 2026

Restoring Continence After Devastating Post-Obstetric Fistula Repair Incontinence: A Pilot Study Comparing Cystoscopic vs Periurethral Bulkamid.

Restoring Continence After Devastating Post-Obstetric Fistula Repair Incontinence: A Pilot Study Comparing Cystoscopic vs Periurethral Bulkamid.

Journal: Neurourology and urodynamics
Published: February 02, 2026

Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments.

Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments.

Journal: Obstetrical & gynecological survey
Published: November 06, 2025

Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels.

Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels.

Journal: Current opinion in urology
Published: October 09, 2025

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial.

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial.

Journal: Neurourology and urodynamics
Published: May 19, 2025

Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments.

Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments.

Journal: Neurourology and urodynamics
Published: May 17, 2025

Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE Trial.

Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE Trial.

Journal: Urology
Published: May 08, 2025

Aquablation Compared with Simple Prostatectomy for Prostate Volumes >80 Grams.

Aquablation Compared with Simple Prostatectomy for Prostate Volumes >80 Grams.

Journal: Journal of endourology
Published: February 21, 2025

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial.

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial.

Journal: The Journal of urology
Published: December 18, 2024

A First-In-Human Feasibility Study of a New Implantable Tibial Nerve Stimulator for Overactive Bladder Syndrome.

A First-In-Human Feasibility Study of a New Implantable Tibial Nerve Stimulator for Overactive Bladder Syndrome.

Journal: Neuromodulation : journal of the International Neuromodulation Society
Published: December 15, 2024
Showing 1-12 of 112

Last Updated: 09/26/2026